Market Place
Sourcing Support
All News #Library
Biotech
Abbvie Halts Development Of Dragonfly Cancer Asset In Midflight
29 Oct 2025 //
FIERCE BIOTECH
Dragonfly Presents Preclinical Data on DF6215 & DF9001 at SITC
07 Nov 2024 //
PR NEWSWIRE
Dragonfly Therapeutics Presents DF6215 Preclinical Data at SITC
07 Nov 2024 //
PR NEWSWIRE
Dragonfly, Merck Collaborate On DF9001 TriNKET Plus KEYTRUDA
21 May 2024 //
PR NEWSWIRE
Dragonfly, Merck Partner to Evaluate DF9001 in Combination with Keytruda
21 May 2024 //
CONTRACT PHARMA
Dragonfly Announces Collaboration Exploring Combinations of DF1001 with Trodelvy
15 Feb 2024 //
PR NEWSWIRE
Dragonfly Announces the Presentation of Phase 1 DF1001 TriNKET Results at ASCO
05 Jun 2023 //
PR NEWSWIRE
Dragonfly to Present Phase 1 DF1001 Monotherapy Dose Escalation Results
02 Jun 2023 //
PR NEWSWIRE
Dr. Joseph E. Eid joins Dragonfly Therapeutics as President of R&D
01 Feb 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.